Ex vivo characterization of particle transport in mucus secretions coating freshly excised mucosal tissues

Molecular Pharmaceutics

Volumn 10, Issue 6, 2013, Pages 2176-2182

  Ensign, Laura M ^a,b   Henning, Andreas ^a,b,d   Schneider, Craig S ^a,b   Maisel, Katharina ^a,c   Wang, Ying Ying ^a,c   Porosoff, Marc D ^a,b,e   Cone, Richard ^a,c   Hanes, Justin ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Johns Hopkins University   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Pharmaceutical Development   (Germany)

^e University of Delaware   (United States)

Author keywords

drug delivery; mucus penetrating particles; particle tracking

Indexed keywords

MEDROXYPROGESTERONE ACETATE; NANOPARTICLE;

ANIMAL TISSUE; ARTICLE; DRUG DELIVERY SYSTEM; EX VIVO STUDY; EXCISION; FEMALE; LUNG PARENCHYMA; MOUSE; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; DRUG DELIVERY SYSTEMS; FEMALE; INTESTINE, SMALL; MICE; MICROSCOPY, FLUORESCENCE; MUCOUS MEMBRANE; NANOPARTICLES; RESPIRATORY SYSTEM; TRACHEA; VAGINA;

EID: 84878663137     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400087y     Document Type: Article

References (42)

1. Ensign, L. M. Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus Sci. Transl. Med. 2012, 4 (138) 138ra179
2. Lai, S. K.; Wang, Y. Y.; Cone, R.; Wirtz, D.; Hanes, J. Altering mucus rheology to "solidify" human mucus at the nanoscale PLoS One 2009, 4 (1) e4294
3. des Rieux, A.; Fievez, V.; Garinot, M.; Schneider, Y. J.; Preat, V. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach J. Controlled Release 2006, 116 (1) 1-27
4. Mallipeddi, R.; Rohan, L. C. Nanoparticle-based vaginal drug delivery systems for HIV prevention Expert Opin. Drug Delivery 2010, 7 (1) 37-48
5. Cone, R. A. Barrier properties of mucus Adv. Drug Delivery Rev. 2009, 61 (2) 75-85
6. Lai, S. K.; Wang, Y. Y.; Hanes, J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues Adv. Drug Delivery Rev. 2009, 61 (2) 158-171
7. Lai, S. K.; Wang, Y. Y.; Hida, K.; Cone, R.; Hanes, J. Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses Proc. Natl. Acad. Sci. U.S.A. 2010, 107 (2) 598-603
8. Lai, S. K. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus Proc. Natl. Acad. Sci. U.S.A. 2007, 104 (5) 1482-1487
9. Dawson, M.; Wirtz, D.; Hanes, J. Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport J. Biol. Chem. 2003, 278 (50) 50393-50401
10. Kararli, T. T. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals Biopharm. Drug Dispos. 1995, 16 (5) 351-380
11. Suk, J. S. N-acetylcysteine enhances cystic fibrosis sputum penetration and airway gene transfer by highly compacted DNA nanoparticles Mol. Ther. 2011, 19 (11) 1981-1989
12. Crater, J. S.; Carrier, R. L. Barrier properties of gastrointestinal mucus to nanoparticle transport Macromol. Biosci. 2010, 10 (12) 1473-1483
13. Olmsted, S. S. Diffusion of macromolecules and virus-like particles in human cervical mucus Biophys. J. 2001, 81 (4) 1930-1937
14. Nance, E. A. A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue Sci. Transl. Med. 2012, 4 (149) 149ra119
15. Wang, Y. Y. Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier Angew. Chem., Int. Ed. 2008, 47 (50) 9726-9729
16. Suh, J.; Dawson, M.; Hanes, J. Real-time multiple-particle tracking: applications to drug and gene delivery Adv. Drug Delivery Rev. 2005, 57 (1) 63-78
17. Kim, A. J. Use of Single-Site-Functionalized PEG Dendrons To Prepare Gene Vectors that Penetrate Human Mucus Barriers Angew. Chem., Int. Ed. 2013, 52 (14) 3985-3988
18. Odeblad, E. The functional structure of human cervical mucus Acta Obstet. Gynecol. Scand. 1968, 47, 57-79
19. Parr, E. L.; Parr, M. B. Immune responses and protection against vaginal infection after nasal or vaginal immunization with attenuated herpes simplex virus type-2 Immunology 1999, 98 (4) 639-645
20. Elstein, M. Functions and physical properties of mucus in the female genital tract Br. Med. Bull. 1978, 34 (1) 83-88
21. Sanders, N.; Rudolph, C.; Braeckmans, K.; De Smedt, S. C.; Demeester, J. Extracellular barriers in respiratory gene therapy Adv. Drug Delivery Rev. 2009, 61 (2) 115-127
22. Ensign, L. M.; Cone, R.; Hanes, J. Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers Adv. Drug Delivery Rev. 2012, 64 (6) 557-570
23. Lichtenberger, L. M. The hydrophobic barrier properties of gastrointestinal mucus Annu. Rev. Physiol. 1995, 57, 565-583
24. Macierzanka, A. Adsorption of bile salts to particles allows penetration of intestinal mucus Soft Matter 2011, 7 (18) 8077-8084
25. Lieleg, O.; Vladescu, I.; Ribbeck, K. Characterization of particle translocation through mucin hydrogels Biophys. J. 2010, 98 (9) 1782-1789
26. Allen, E. The oestrous cycle in the mouse Am. J. Anat. 1922, 30 (3) 297-371
27. Dalal, S. J.; Estep, J. S.; Valentin-Bon, I. E.; Jerse, A. E. Standardization of the Whitten Effect to induce susceptibility to Neisseria gonorrhoeae in female mice Contemp. Top. Lab. Anim. Sci. 2001, 40 (2) 13-17
28. Zeitlin, L.; Whaley, K. J.; Hegarty, T. A.; Moench, T. R.; Cone, R. A. Tests of vaginal microbicides in the mouse genital herpes model Contraception 1997, 56 (5) 329-335
29. Asscher, A. W.; Turner, C. J.; Deboer, C. H. Cornification of the Human Vaginal Epithelium J. Anat. 1956, 90 (4) 547-552-1
30. Smith, B. G.; Brunner, E. K. The structure of the human vaginal mucosa in relation to the menstrual cycle and to pregnancy Am. J. Anat. 1934, 54 (1) 27-85
31. Moench, T. R.; Mumper, R. J.; Hoen, T. E.; Sun, M.; Cone, R. A. Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse BMC Infect. Dis. 2010, 10.1186/1471-2334-10-331
32. Wilson, S. S. Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety Antiviral Ther. 2009, 14 (8) 1113-1124
33. Woodrow, K. A. Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA Nat. Mater. 2009, 8 (6) 526-533
34. Cu, Y.; Booth, C. J.; Saltzman, W. M. In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery J. Controlled Release 2011, 156 (2) 258-264
35. Kanazawa, T. Effective vaginal DNA delivery with high transfection efficiency is a good system for induction of higher local vaginal immune responses J. Pharm. Pharmacol. 2009, 61 (11) 1457-1463
36. Seavey, M. M.; Mosmann, T. R. Estradiol-induced vaginal mucus inhibits antigen penetration and CD8(+) T cell priming in response to intravaginal immunization Vaccine 2009, 27 (17) 2342-2349
37. Kirch, J. Optical tweezers reveal relationship between microstructure and nanoparticle penetration of pulmonary mucus Proc. Natl. Acad. Sci. U.S.A. 2012, 109 (45) 18355-18360
38. Suk, J. S. The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles Biomaterials 2009, 30 (13) 2591-2597
39. Schuster, B. S.; Suk, J. S.; Woodworth, G. F.; Hanes, J. Nanoparticle diffusion in respiratory mucus from humans without lung disease Biomaterials 2013, 34 (13) 3439-3446
40. Lai, S. K. Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus Biomaterials 2011, 32 (26) 6285-6290
41. Louissaint, N. A. Distribution of cell-free and cell-associated HIV surrogates in the female genital tract after simulated vaginal intercourse J. Infect. Dis. 2012, 205 (5) 725-732
42. Louissaint, N. A. Distribution of Cell-Free and Cell-Associated HIV Surrogates in the Colon After Simulated Receptive Anal Intercourse in Men Who Have Sex With Men JAIDS, J. Acquired Immune Defic. Syndr. 2012, 59 (1) 10-17